nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylbutazone—CYP3A4—type 2 diabetes mellitus	0.147	0.505	CbGaD
Phenylbutazone—PTGS2—type 2 diabetes mellitus	0.144	0.495	CbGaD
Phenylbutazone—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.0396	0.0696	CbGbCtD
Phenylbutazone—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.0396	0.0696	CbGbCtD
Phenylbutazone—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.0366	0.0642	CbGbCtD
Phenylbutazone—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.0347	0.061	CbGbCtD
Phenylbutazone—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.031	0.0544	CbGbCtD
Phenylbutazone—PTGS1—Nateglinide—type 2 diabetes mellitus	0.03	0.0527	CbGbCtD
Phenylbutazone—PTGS1—Irbesartan—type 2 diabetes mellitus	0.0288	0.0506	CbGbCtD
Phenylbutazone—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.0263	0.0463	CbGbCtD
Phenylbutazone—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0221	0.0388	CbGbCtD
Phenylbutazone—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0202	0.0354	CbGbCtD
Phenylbutazone—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0188	0.0329	CbGbCtD
Phenylbutazone—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0178	0.0312	CbGbCtD
Phenylbutazone—SLC22A6—Losartan—type 2 diabetes mellitus	0.0163	0.0286	CbGbCtD
Phenylbutazone—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0159	0.028	CbGbCtD
Phenylbutazone—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0159	0.028	CbGbCtD
Phenylbutazone—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0147	0.0259	CbGbCtD
Phenylbutazone—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0144	0.0253	CbGbCtD
Phenylbutazone—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0142	0.025	CbGbCtD
Phenylbutazone—CYP2C9—Valsartan—type 2 diabetes mellitus	0.013	0.0228	CbGbCtD
Phenylbutazone—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0128	0.0225	CbGbCtD
Phenylbutazone—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0121	0.0212	CbGbCtD
Phenylbutazone—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0117	0.0206	CbGbCtD
Phenylbutazone—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0116	0.0204	CbGbCtD
Phenylbutazone—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0103	0.018	CbGbCtD
Phenylbutazone—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00927	0.0163	CbGbCtD
Phenylbutazone—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00816	0.0143	CbGbCtD
Phenylbutazone—CYP2C9—Losartan—type 2 diabetes mellitus	0.00747	0.0131	CbGbCtD
Phenylbutazone—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00703	0.0123	CbGbCtD
Phenylbutazone—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00674	0.0118	CbGbCtD
Phenylbutazone—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00674	0.0118	CbGbCtD
Phenylbutazone—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00637	0.0112	CbGbCtD
Phenylbutazone—PTGIS—artery—type 2 diabetes mellitus	0.00595	0.162	CbGeAlD
Phenylbutazone—PTGIS—endothelium—type 2 diabetes mellitus	0.00503	0.137	CbGeAlD
Phenylbutazone—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00475	0.00834	CbGbCtD
Phenylbutazone—CYP3A4—Losartan—type 2 diabetes mellitus	0.00434	0.00763	CbGbCtD
Phenylbutazone—PTGIS—cardiovascular system—type 2 diabetes mellitus	0.00207	0.0562	CbGeAlD
Phenylbutazone—PTGS2—leg—type 2 diabetes mellitus	0.00195	0.0529	CbGeAlD
Phenylbutazone—PTGIS—adipose tissue—type 2 diabetes mellitus	0.00182	0.0495	CbGeAlD
Phenylbutazone—PTGS2—hindlimb—type 2 diabetes mellitus	0.00174	0.0472	CbGeAlD
Phenylbutazone—SLC22A11—nephron tubule—type 2 diabetes mellitus	0.00129	0.035	CbGeAlD
Phenylbutazone—PTGIS—liver—type 2 diabetes mellitus	0.00128	0.0347	CbGeAlD
Phenylbutazone—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.00122	0.033	CbGeAlD
Phenylbutazone—SLC22A11—kidney—type 2 diabetes mellitus	0.00113	0.0308	CbGeAlD
Phenylbutazone—PTGS1—artery—type 2 diabetes mellitus	0.00112	0.0303	CbGeAlD
Phenylbutazone—SLC22A11—cortex of kidney—type 2 diabetes mellitus	0.0011	0.03	CbGeAlD
Phenylbutazone—PTGS2—artery—type 2 diabetes mellitus	0.00107	0.029	CbGeAlD
Phenylbutazone—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.00104	0.0282	CbGeAlD
Phenylbutazone—PTGS1—endothelium—type 2 diabetes mellitus	0.000942	0.0256	CbGeAlD
Phenylbutazone—PTGS2—endothelium—type 2 diabetes mellitus	0.000901	0.0245	CbGeAlD
Phenylbutazone—SLC22A8—nephron tubule—type 2 diabetes mellitus	0.000727	0.0197	CbGeAlD
Phenylbutazone—SLC22A11—liver—type 2 diabetes mellitus	0.000716	0.0194	CbGeAlD
Phenylbutazone—SLC22A8—kidney—type 2 diabetes mellitus	0.000639	0.0174	CbGeAlD
Phenylbutazone—SLC22A8—cortex of kidney—type 2 diabetes mellitus	0.000623	0.0169	CbGeAlD
Phenylbutazone—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.000512	0.0139	CbGeAlD
Phenylbutazone—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000425	0.0115	CbGeAlD
Phenylbutazone—PTGS1—cardiovascular system—type 2 diabetes mellitus	0.000388	0.0105	CbGeAlD
Phenylbutazone—PTGS1—kidney—type 2 diabetes mellitus	0.000379	0.0103	CbGeAlD
Phenylbutazone—PTGS2—cardiovascular system—type 2 diabetes mellitus	0.000371	0.0101	CbGeAlD
Phenylbutazone—PTGS2—kidney—type 2 diabetes mellitus	0.000363	0.00984	CbGeAlD
Phenylbutazone—PTGS2—pancreas—type 2 diabetes mellitus	0.00036	0.00978	CbGeAlD
Phenylbutazone—PTGS1—adipose tissue—type 2 diabetes mellitus	0.000342	0.00928	CbGeAlD
Phenylbutazone—Sulfinpyrazone—ABCC2—type 2 diabetes mellitus	0.000338	0.115	CrCbGaD
Phenylbutazone—Phenoxybenzamine—CALM1—type 2 diabetes mellitus	0.000331	0.113	CrCbGaD
Phenylbutazone—PTGS2—adipose tissue—type 2 diabetes mellitus	0.000327	0.00887	CbGeAlD
Phenylbutazone—CYP3A4—kidney—type 2 diabetes mellitus	0.000317	0.0086	CbGeAlD
Phenylbutazone—CYP2C9—liver—type 2 diabetes mellitus	0.000263	0.00713	CbGeAlD
Phenylbutazone—PTGS2—liver—type 2 diabetes mellitus	0.000229	0.00622	CbGeAlD
Phenylbutazone—CYP3A4—liver—type 2 diabetes mellitus	0.0002	0.00544	CbGeAlD
Phenylbutazone—Fosphenytoin—CYP3A4—type 2 diabetes mellitus	0.000167	0.0569	CrCbGaD
Phenylbutazone—Phenytoin—ABCC2—type 2 diabetes mellitus	0.000167	0.0569	CrCbGaD
Phenylbutazone—Oxaprozin—PTGS2—type 2 diabetes mellitus	0.000157	0.0536	CrCbGaD
Phenylbutazone—Benzphetamine—ADRA2A—type 2 diabetes mellitus	0.000157	0.0534	CrCbGaD
Phenylbutazone—Phenoxybenzamine—ADRA2A—type 2 diabetes mellitus	0.00015	0.0511	CrCbGaD
Phenylbutazone—Sulfinpyrazone—CYP3A4—type 2 diabetes mellitus	0.000149	0.0508	CrCbGaD
Phenylbutazone—Fosphenytoin—ALB—type 2 diabetes mellitus	0.000146	0.0496	CrCbGaD
Phenylbutazone—Modafinil—CYP1A2—type 2 diabetes mellitus	0.000126	0.0428	CrCbGaD
Phenylbutazone—Phenprocoumon—CYP3A4—type 2 diabetes mellitus	0.000114	0.039	CrCbGaD
Phenylbutazone—Phenprocoumon—ALB—type 2 diabetes mellitus	9.99e-05	0.034	CrCbGaD
Phenylbutazone—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	8.73e-05	0.0297	CrCbGaD
Phenylbutazone—Methadone—CYP1A2—type 2 diabetes mellitus	8.43e-05	0.0287	CrCbGaD
Phenylbutazone—Modafinil—CYP3A4—type 2 diabetes mellitus	8.32e-05	0.0283	CrCbGaD
Phenylbutazone—Dextropropoxyphene—CYP3A4—type 2 diabetes mellitus	8.22e-05	0.028	CrCbGaD
Phenylbutazone—Fentanyl—CYP3A4—type 2 diabetes mellitus	8.13e-05	0.0277	CrCbGaD
Phenylbutazone—Clobazam—CYP3A4—type 2 diabetes mellitus	8.09e-05	0.0276	CrCbGaD
Phenylbutazone—Phenytoin—CYP3A4—type 2 diabetes mellitus	7.38e-05	0.0251	CrCbGaD
Phenylbutazone—Benzphetamine—CYP3A4—type 2 diabetes mellitus	7.21e-05	0.0246	CrCbGaD
Phenylbutazone—Phenoxybenzamine—CYP3A4—type 2 diabetes mellitus	6.89e-05	0.0235	CrCbGaD
Phenylbutazone—Phenytoin—ALB—type 2 diabetes mellitus	6.43e-05	0.0219	CrCbGaD
Phenylbutazone—Methadone—CYP3A4—type 2 diabetes mellitus	5.58e-05	0.019	CrCbGaD
Phenylbutazone—PTGS2—Metabolism—HBA1—type 2 diabetes mellitus	9.21e-06	9.21e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GCK—type 2 diabetes mellitus	9.21e-06	9.21e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NCOA6—type 2 diabetes mellitus	9.19e-06	9.19e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	9.18e-06	9.18e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CYP3A4—type 2 diabetes mellitus	9.18e-06	9.18e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP11A1—type 2 diabetes mellitus	9.16e-06	9.16e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	9.13e-06	9.13e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HSD11B1—type 2 diabetes mellitus	9.03e-06	9.03e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—UCP2—type 2 diabetes mellitus	9.03e-06	9.03e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—UCP3—type 2 diabetes mellitus	9.03e-06	9.03e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GCG—type 2 diabetes mellitus	9.03e-06	9.03e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—SLC2A4—type 2 diabetes mellitus	9.03e-06	9.03e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SLC9A1—type 2 diabetes mellitus	8.99e-06	8.99e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SLC2A1—type 2 diabetes mellitus	8.92e-06	8.92e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CETP—type 2 diabetes mellitus	8.89e-06	8.89e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	8.82e-06	8.82e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NOS1—type 2 diabetes mellitus	8.79e-06	8.8e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	8.76e-06	8.76e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	8.73e-06	8.73e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TCF7L2—type 2 diabetes mellitus	8.7e-06	8.7e-05	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—IL6—type 2 diabetes mellitus	8.61e-06	8.61e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SLC2A4—type 2 diabetes mellitus	8.56e-06	8.56e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	8.49e-06	8.49e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	8.36e-06	8.36e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	8.29e-06	8.29e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PSMD6—type 2 diabetes mellitus	8.26e-06	8.26e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SNAP25—type 2 diabetes mellitus	8.26e-06	8.26e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SREBF1—type 2 diabetes mellitus	8.26e-06	8.26e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	8.16e-06	8.16e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	8.14e-06	8.14e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	8.14e-06	8.14e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CTGF—type 2 diabetes mellitus	8.11e-06	8.11e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—HMGCR—type 2 diabetes mellitus	8.04e-06	8.04e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	7.95e-06	7.95e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	7.94e-06	7.94e-05	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—AKT1—type 2 diabetes mellitus	7.94e-06	7.94e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	7.93e-06	7.93e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ADRA2A—type 2 diabetes mellitus	7.87e-06	7.87e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	7.86e-06	7.86e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	7.86e-06	7.86e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	7.86e-06	7.86e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	7.86e-06	7.86e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	7.86e-06	7.86e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GNB3—type 2 diabetes mellitus	7.78e-06	7.78e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.78e-06	7.78e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—HMOX1—type 2 diabetes mellitus	7.74e-06	7.74e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	7.68e-06	7.68e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	7.68e-06	7.68e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	7.68e-06	7.68e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	7.68e-06	7.68e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CAT—type 2 diabetes mellitus	7.64e-06	7.64e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	7.61e-06	7.61e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP2E1—type 2 diabetes mellitus	7.56e-06	7.56e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP1A2—type 2 diabetes mellitus	7.47e-06	7.47e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SLC2A1—type 2 diabetes mellitus	7.47e-06	7.47e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TGFBR2—type 2 diabetes mellitus	7.44e-06	7.44e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—APOB—type 2 diabetes mellitus	7.42e-06	7.42e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	7.38e-06	7.39e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	7.36e-06	7.36e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP3A4—type 2 diabetes mellitus	7.29e-06	7.29e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GSTM1—type 2 diabetes mellitus	7.22e-06	7.22e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CDKN2B—type 2 diabetes mellitus	7.21e-06	7.21e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	7.19e-06	7.19e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	7.19e-06	7.19e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SLC2A4—type 2 diabetes mellitus	7.16e-06	7.17e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GCG—type 2 diabetes mellitus	7.16e-06	7.17e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	7.15e-06	7.15e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—LPL—type 2 diabetes mellitus	7.08e-06	7.08e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—APOB—type 2 diabetes mellitus	7.03e-06	7.03e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	7.01e-06	7.01e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	7.01e-06	7.01e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ADCY5—type 2 diabetes mellitus	6.93e-06	6.93e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	6.93e-06	6.93e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GPX1—type 2 diabetes mellitus	6.91e-06	6.91e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	6.85e-06	6.85e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CD36—type 2 diabetes mellitus	6.73e-06	6.73e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—LPL—type 2 diabetes mellitus	6.71e-06	6.71e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	6.68e-06	6.68e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	6.68e-06	6.68e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	6.68e-06	6.68e-05	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—AKT1—type 2 diabetes mellitus	6.65e-06	6.65e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PPP2CA—type 2 diabetes mellitus	6.64e-06	6.65e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ADCY5—type 2 diabetes mellitus	6.57e-06	6.57e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	6.41e-06	6.41e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	6.41e-06	6.41e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	6.39e-06	6.39e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—MTHFR—type 2 diabetes mellitus	6.38e-06	6.38e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PPP2CA—type 2 diabetes mellitus	6.3e-06	6.3e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	6.26e-06	6.26e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	6.26e-06	6.26e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PPARA—type 2 diabetes mellitus	6.26e-06	6.26e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CCR5—type 2 diabetes mellitus	6.19e-06	6.19e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GNB3—type 2 diabetes mellitus	6.18e-06	6.18e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.18e-06	6.18e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	6.17e-06	6.17e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	6.17e-06	6.17e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—HMOX1—type 2 diabetes mellitus	6.15e-06	6.15e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	6.14e-06	6.14e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	6.1e-06	6.1e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	6.1e-06	6.1e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	6.1e-06	6.1e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	6.1e-06	6.1e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CAT—type 2 diabetes mellitus	6.07e-06	6.07e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	6.06e-06	6.06e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	6.06e-06	6.06e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—AGT—type 2 diabetes mellitus	6.06e-06	6.06e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MTHFR—type 2 diabetes mellitus	6.04e-06	6.04e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CALM1—type 2 diabetes mellitus	5.96e-06	5.96e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	5.96e-06	5.96e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	5.96e-06	5.96e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	5.96e-06	5.96e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	5.95e-06	5.96e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—APOE—type 2 diabetes mellitus	5.94e-06	5.94e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	5.89e-06	5.89e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	5.89e-06	5.89e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—APOA1—type 2 diabetes mellitus	5.87e-06	5.87e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	5.76e-06	5.76e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IRS2—type 2 diabetes mellitus	5.75e-06	5.75e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	5.73e-06	5.73e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CALM1—type 2 diabetes mellitus	5.65e-06	5.65e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—APOE—type 2 diabetes mellitus	5.63e-06	5.63e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	5.62e-06	5.62e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	5.6e-06	5.6e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—APOA1—type 2 diabetes mellitus	5.56e-06	5.56e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	5.5e-06	5.5e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.49e-06	5.49e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	5.49e-06	5.49e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	5.47e-06	5.47e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	5.47e-06	5.47e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	5.47e-06	5.47e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	5.37e-06	5.37e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	5.34e-06	5.34e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	5.32e-06	5.32e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	5.28e-06	5.28e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.25e-06	5.25e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.24e-06	5.24e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NOS2—type 2 diabetes mellitus	5.24e-06	5.24e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	5.21e-06	5.21e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	5.17e-06	5.17e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—INS—type 2 diabetes mellitus	5.07e-06	5.07e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.07e-06	5.07e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.07e-06	5.07e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.07e-06	5.07e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.07e-06	5.07e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	5.06e-06	5.06e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IRS1—type 2 diabetes mellitus	5.02e-06	5.02e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	5.01e-06	5.01e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	4.97e-06	4.97e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	4.95e-06	4.95e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	4.95e-06	4.95e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.86e-06	4.86e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	4.83e-06	4.83e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	4.81e-06	4.81e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—INS—type 2 diabetes mellitus	4.81e-06	4.81e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.8e-06	4.8e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	4.74e-06	4.75e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	4.74e-06	4.75e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	4.73e-06	4.73e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	4.71e-06	4.71e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	4.66e-06	4.66e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	4.65e-06	4.65e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—AKT2—type 2 diabetes mellitus	4.65e-06	4.65e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.51e-06	4.51e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	4.45e-06	4.45e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.45e-06	4.45e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	4.42e-06	4.42e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	4.22e-06	4.22e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NOS3—type 2 diabetes mellitus	4.22e-06	4.22e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.21e-06	4.21e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.13e-06	4.13e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.13e-06	4.13e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	4.1e-06	4.11e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	4.09e-06	4.09e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.09e-06	4.09e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	4.07e-06	4.07e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	4.07e-06	4.07e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.05e-06	4.05e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—INS—type 2 diabetes mellitus	4.03e-06	4.03e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.02e-06	4.02e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.02e-06	4.02e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.02e-06	4.02e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	4.02e-06	4.02e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4e-06	4e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.93e-06	3.93e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	3.9e-06	3.9e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.88e-06	3.88e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	3.79e-06	3.79e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	3.72e-06	3.72e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	3.69e-06	3.69e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	3.64e-06	3.65e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	3.63e-06	3.63e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.61e-06	3.61e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.61e-06	3.61e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.61e-06	3.61e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.54e-06	3.54e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	3.54e-06	3.54e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.53e-06	3.53e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	3.53e-06	3.53e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.51e-06	3.51e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	3.49e-06	3.49e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.44e-06	3.44e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	3.35e-06	3.35e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.3e-06	3.3e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	3.29e-06	3.29e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.26e-06	3.26e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.26e-06	3.26e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	3.19e-06	3.19e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	3.13e-06	3.13e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.13e-06	3.13e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.13e-06	3.13e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	3.12e-06	3.12e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SRC—type 2 diabetes mellitus	3.12e-06	3.12e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	3.09e-06	3.09e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	2.79e-06	2.79e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—EGFR—type 2 diabetes mellitus	2.73e-06	2.73e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.72e-06	2.72e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.7e-06	2.7e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.7e-06	2.7e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.68e-06	2.68e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.67e-06	2.67e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.65e-06	2.65e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.57e-06	2.57e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.5e-06	2.5e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.46e-06	2.46e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.44e-06	2.44e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.4e-06	2.4e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.4e-06	2.4e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.34e-06	2.34e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	2.34e-06	2.34e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.33e-06	2.33e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.3e-06	2.3e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.21e-06	2.21e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.17e-06	2.17e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	2.14e-06	2.14e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.1e-06	2.1e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IL6—type 2 diabetes mellitus	2.1e-06	2.1e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.07e-06	2.07e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.06e-06	2.06e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	2.04e-06	2.04e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.03e-06	2.03e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—AKT1—type 2 diabetes mellitus	1.94e-06	1.94e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.79e-06	1.79e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.76e-06	1.76e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	1.62e-06	1.62e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.61e-06	1.61e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.54e-06	1.54e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.54e-06	1.54e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.41e-06	1.41e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.07e-06	1.07e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	7.09e-07	7.09e-06	CbGpPWpGaD
